CSL Ltd. - ADR

CSL Ltd. - ADR

CSLLY

Get informed when a big investor buys or sells

+ Follow
Market Cap$91.08B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
CSL Ltd. - ADRCSL Ltd. - ADR31.43.22%22%3.50.7

Earnings Call Q4 2023

August 15, 2023 - AI Summary

CSL delivered strong full-year results, with revenue up 31% at constant currency and NPATA of $2.6 billion, up 20%.
The CSL Behring business saw strong growth in its Ig franchise, with sales up 21%. Plasma collections reached record levels, and the company dosed its first patients with HEMGENIX, a gene therapy for hemophilia B.
CSL Seqirus achieved strong sales growth, driven by FLUCELVAX, which was up 30%. The company also signed a licensing agreement with Arcturus Therapeutics for next-generation mRNA vaccine technology.

Exclusive for Stockcircle Pro members

Sign upSign Up
$25.35

Current Fair Value

4.7% upside

Undervalued by 4.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$91.08 Billion
Enterprise Value$102.50 Billion
Dividend Yield$0.72 (3.22%)
Earnings per Share$0.39
Beta0.08
Outstanding Shares3,868,601,992

Return

Return on Equity22.39%ROE
Return on Assets11.02%
Return on Invested Capital23.77%

Valuation & Multiples

P/E Ratio31.36P/E Ratio
PEG-39.21PEG
Price to Sales3.46Price to Sales
Price to Book Ratio4.84Price to Book Ratio
Enterprise Value to Revenue3.37
Enterprise Value to EBIT12.95
Enterprise Value to Net Income24
Total Debt to Enterprise0.12
Debt to Equity0.67Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
February 10, 2026
EPS Estimate
-
Average shareholder expectation
Revenue Estimate
-
Average shareholder expectation

Next Earnings Call

Expected Date
August 17, 2026
EPS Estimate
-
Average shareholder expectation
Revenue Estimate
-
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.00%0%
Total Invested$1.42M▲ 75.20%
Investors Holding7▼ 1.00%

ESG Score

No data

About CSL Ltd.

CEO: Paul Perreault